Thomas Gajewski, M.D., Ph.D.

University of Chicago
Chicago, IL

Dr. Thomas F. Gajewski is a professor in both the Ben May Department for Cancer Research and the Department of Pathology at the University of Chicago.

Dr. Gajewski, who received the first American Cancer Society-Jules L. Plangere Jr. Family Foundation Professor in Cancer Immunotherapy Award as well as the 2017 William B. Coley Award for Distinguished Research in Tumor Immunology, is known for his work on the development, activation, and regulation of T cells, and he remains committed to translating those laboratory efforts into clinical strategies that can improve anti-tumor immune responses in patients.

In addition to being a member of CRI’s Scientific Advisory Council, Dr. Gajewski serves on the CLIP Grant Review Committee.

The field has recently recognized close connections between the gut microbiome and the immune system. This finding provides a novel way to exploit that connection, to improve immunotherapy by selectively modulating intestinal bacteria.
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.